Diabetes
-
New Pathway Found to Combat Diabetic Ulcer Inflammation
Researchers have identified a molecular axis involving the STING pathway that drives diabetic ulcer development, offering a potential new therapeutic target.
-
Novo Nordisk CEO Unveils Aggressive Strategy to Reclaim GLP-1 Market Lead, Targets 2 Billion People
Novo Nordisk’s new CEO Maziar Mike Doustdar outlines a bold three-pronged strategy for 2026, aiming to reclaim market dominance in the GLP-1 obesity drug sector from rival Eli Lilly. The plan focuses on commercial execution, pipeline progression, and a return…
-
Ozempic and GLP-1 Drugs: New Safety Warnings on Mental Health and Contraception Risks
Australian regulators have updated safety warnings for Ozempic and related GLP-1 drugs, citing potential mental health risks and contraceptive effectiveness concerns. While evidence of a direct link is inconclusive, authorities advise caution and closer monitoring for vulnerable patients.